டெர்ரி சாலயேற் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டெர்ரி சாலயேற். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டெர்ரி சாலயேற் Today - Breaking & Trending Today

InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization


InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization
USA - English
Share this article
Share this article
BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/  InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray
® Measles and Rubella (MR) antigen quantification kit. 
Funded by the Bill and Melinda Gates Foundation with the goal of reducing the time and cost of manufacturing for these life-saving vaccines, InDevR s VaxArray MR kit leverages the company s established VaxArray
® platform to deliver a rapid quantitative analysis of specific measles and rubella antigens. The VaxArray MR kit provides a precise measure of antigen content in 5 hours, which is a fraction of the time needed for the traditional 10-14-day tissue culture infectious dose measurement. The ....

United States , Andhra Pradesh , Terry Salyer , Senthilkumar Manoharan , Erica Dawson , Analytical Development Vaccines , Indevr Inc , Melinda Gates Foundation , General Manager , Analytical Development , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , டெர்ரி சாலயேற் , செந்தில்குமர் மனோஹரன் , எரிகா டாசன் , பகுப்பாய்வு வளர்ச்சி தடுப்பு மருந்துகள் , மெலிண்டா வாயில்கள் அடித்தளம் , ஜநரல் மேலாளர் , பகுப்பாய்வு வளர்ச்சி ,

InDevR Expands Commercial Portfolio for Coronavirus Vaccine Characterization


InDevR Expands Commercial Portfolio for Coronavirus Vaccine Characterization
USA - English
Share this article
Share this article
BOULDER, Colo., Dec. 10, 2020 /PRNewswire/  InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Spike Protein Kit and SARS-CoV-2 Spike Protein Standard for vaccine antigen quantification.
Of the many coronavirus vaccine candidates in development, several are based on either whole virus or recombinant spike-protein. Quantification of the spike protein concentration, or potency, at various steps in the manufacturing process is critical for characterizing vaccine performance. Many developers rely on in-house immunoassays for early protein quantification work. To streamline vaccine development, InDevR offers an off-the-shelf VaxArray kit for multiplexed quantification of sp ....

Terry Salyer , Kathy Rowlen , Indevr Inc , Spike Protein Kit , Protein Standard , Vaxarray Coronavirus Seroassay , டெர்ரி சாலயேற் , ஸ்பைக் ப்ரோடீந் கிட் , ப்ரோடீந் தரநிலை ,